Karyopharm Therapeutics Inc. · NASDAQ:KPTI
JPMorgan Chase & Co's stake in Karyopharm Therapeutics Inc. fell to 4.90% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 17, 2025
JPMorgan Chase & Co's stake in Karyopharm Therapeutics Inc. fell to 4.90%, 427,624 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 427,624
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 4.90% | 427,624 |
Source
Related
- Karyopharm Therapeutics Inc.
- JPMorgan Chase & Co
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2025
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026